Search Results
Dec 09, 2025, 12:00 ET Code and Theory Named Adweek's Inaugural Innovation Agency of the Year
the intersection of technology and creativity. This pairing shapes everything we do, from our founding and our growth to our people, our process, our DNA and even our name, Code and Theory. Adweek's recognition is proof that this approach matters. I'm grateful to our teams who make it possible every day
More news about: Stagwell Inc.
Dec 09, 2025, 10:32 ET Global Skin Health Supplement Market Forecast: USD 2.57 Billion in 2025 to USD 4.62 Billion by 2035 -- Future Market Insights, Inc. Report
wellness creators accelerate adoption of beauty-from-within science.4. Rapid Expansion of Personalized NutritionAI-based diagnostics, DNA-based beauty solutions, and biomarker-driven supplement plans are becoming mainstream.Collagen Takes Center Stage — A 32% Market Share LeaderCollagen-based
More news about: Future Market Insights
Dec 09, 2025, 09:30 ET Lung Cancer Research Foundation Announces Recipients of LCRF | Boehringer Ingelheim Early Investigator Awards
patients with HER2-driven NSCLCElizabeth Brunk, PhDThe University of North Carolina at Chapel HillLinking Structural DNA Variation to Therapeutic Response and Resistance in HER2-Mutated NSCLCPaul Stockhammer, MD, PhDYale UniversityMolecular
More news about: Lung Cancer Research Foundation
Dec 09, 2025, 09:10 ET MDA SPACE SIGNS STRATEGIC PARTNERSHIP WITH THE DEPARTMENT OF NATIONAL DEFENCE AND TELESAT TO DELIVER MILITARY SATELLITE COMMUNICATIONS
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Dec 09, 2025, 09:00 ET Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Dec 09, 2025, 09:00 ET TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.
Oncobit's proprietary Personalized Monitoring (PM) platform, including a cutting-edge data interpretation software, to track changes in circulating tumor DNA (ctDNA). Research shows that ctDNA dynamics assessed with Oncobit™ PM can predict treatment response and progression, underscoring its value as a powerful
More news about: TrilliumBiO
Dec 09, 2025, 08:41 ET Yenos Analytical Launches the Yenos Test, First-of-its-Kind Multi-Cancer Early Detection Urine Test
"MicroRNA biomarker literature suggests that the same test may identify practically all cancers including brain cancer which cannot be identified by DNA- or protein-derived biomarkers."With a simple urine sample collected at home and shipped by FedEx, the Yenos test can detect signals from 6 cancer
More news about: Yenos Analytical LLC
Dec 09, 2025, 08:33 ET Korea University Researchers Develop Ultrasensitive Method to Detect Low-Frequency Cancer Mutations
exceptional precision. The variant shows near-zero off-target activity and selectively cleaves perfectly matched wild-type DNA, thereby enriching the relative proportion of circulating tumor DNA before sequencing. This enrichment allows rare variants to rise above the intrinsic noise that commonly limits next-generation
More news about: Korea University College of Medicine
Dec 09, 2025, 08:01 ET Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
Report includes nearly 12,000 patients who underwent Lucid's EsoGuard® Esophageal DNA Test on samples collected using its EsoCheck® Esophageal Cell Collection DeviceReal-world data confirm excellent technical performance, very rapid
More news about: Lucid Diagnostics
Dec 09, 2025, 08:00 ET Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
BOSTON, Dec. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Deep Origin on a 4.5-year project funded by the Advanced Research Projects Agency for Health (ARPA-H) Computational ADME-Tox
More news about: Ginkgo Bioworks
Dec 09, 2025, 06:01 ET Target Opens "Target SoHo" -- a Design-Forward Shoppable Concept Store in SoHo, New York
in the heart of New York City at 600 Broadway, Target SoHo marks a bold new chapter in Target's commitment to style and design, bringing the brand's DNA to life in an immersive, experiential format that's as shoppable as it is inspiring.
More news about: Target Corporation
Dec 09, 2025, 02:29 ET Hanwha Life CGO Dong-Won Kim Reaffirms Commitment to Strengthening South Korea-UAE Financial Cooperation at ADFW 2025
a "100-year Partnership" between the two nations for the next generation.Dong-Won Kim emphasized that South Korea and the UAE "share a common DNA – one that transforms crises into opportunities, embraces change with courage, and values trust-based, long-term partnerships." He added that finance
More news about: Hanwha Life
Dec 09, 2025, 01:54 ET GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy
Dec. 9, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) fragmentation patterns in 1,154 healthy individuals has been published in Clinical Chemistry (Impact Factor 6.3, 2025). The findings reveal key
More news about: GC Genome
Dec 08, 2025, 21:20 ET HKEX Expands Index Business with Launch of HKEX Tech 100 Index
its index and data business. This new broad-based index covers the leading innovative sectors in our listed issuer universe that have transformed the DNA of Hong Kong's markets, and its launch underscores the critical role our markets play in nurturing these emerging industries. This new benchmark provides
More news about: Hong Kong Exchanges and Clearing Limited (HKEX)
Dec 08, 2025, 12:36 ET Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Dec 08, 2025, 10:50 ET Nutraceutical Excipients Market Driven by Expanding Dietary Supplement Demand and Advanced Formulation Technologies - Market Research Intellect
modular formulation, multi-active blends, and personalized packaging formats are increasingly in demand. Companies developing tailored health kits, DNA-based supplements, and age-specific formulations rely on excipients that ensure stability and consistency across numerous product variations. Additionally,
More news about: Market Research Intellect
Dec 08, 2025, 10:30 ET Taiho Oncology Presents Data on All-Oral Regimens Azacitidine and Cedazuridine, and Decitabine and Cedazuridine at the 2025 American Society of Hematology Annual Meeting and Exposition
course of standard-dose decitabine in patients with lower-risk MDS.Azacitidine and decitabine belong to a class of antineoplastic agents known as DNA methyltransferase inhibitors (DMTIs). Each is paired with cedazuridine, a cytidine deaminase inhibitor, to help the agent stay active in the body without
More news about: Taiho Oncology
Dec 08, 2025, 09:01 ET Main Post Partners Announces Sale of KUIU to Conservation-Focused Investor Group
organization, supported our efforts to expand east of the Rockies, and broaden our product line while always protecting the core innovative & performance DNA that makes this brand unique. Just as importantly, they respected our team, guides and customers, allowing us to remain true to serving KUIU nation.
More news about: Main Post Partners
Dec 08, 2025, 08:00 ET Dave's Hot Chicken Appoints Brandon Rhoten as Chief Marketing Officer to Ignite Brand's Next Era of Growth
capabilities."From the moment I started working with the Dave's team, I knew the brand was something special," said Rhoten. "Dave's Hot Chicken has the exact DNA where I've historically done my best work. It's a bold, social-led brand with great food, strong operations, and a willingness to take risks. My goal
More news about: Dave's Hot Chicken
Dec 08, 2025, 05:35 ET Exosomes Market Led by North America with 53% Revenue Share and Global Market Size Set to Surpass USD 2B by 2030, Says Mordor Intelligence
Spectrometry By Biomolecule Type Non-coding RNA (miRNA, lncRNA)Proteins & PeptidesLipidsmRNADNA FragmentsBy Application Diagnostics Cancer Neuro-degenerative Diseases Infectious
More news about: Mordor Intelligence Private Limited
Dec 08, 2025, 01:36 ET GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
- First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025
More news about: GC Biopharma
Dec 07, 2025, 12:01 ET Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
proteins that are 8x more active than normal. These genetic instructions remain in the target cells, but generally do not become a part of a person's own DNA. Once delivered, the new genetic instructions allow the cellular machinery to produce stable levels of factor IX.Important Safety Information (ISI)What
More news about: CSL
Dec 05, 2025, 11:00 ET Cue Chef Innovation Launches Cube O1: The World's First Thermal-AI Cooking Assistant
Privacy, and Community1. Cue: Capturing Your Culinary DNAWhen you cook a dish with Cube O1, it captures the recipe's essential fingerprint—the exact time, temperature, and key transition points. This "Cooking DNA" liberates your recipe from being tied to one specific pot or stove.
More news about: Cue Chef Innovation
Dec 05, 2025, 10:00 ET Preliminary Data from FANSS Study Show Potential for Blood-Based Lung Cancer Detection in Non-Smoking Population
discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments in the blood. The DELFI platform applies advanced machine-learning technology to whole-genome sequencing data to assess individuals'
More news about: DELFI Diagnostics
Dec 05, 2025, 08:33 ET Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC
BOSTON, Dec. 5, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has been awarded by the
More news about: Ginkgo Bioworks